Literature DB >> 3730258

Comparative studies between a new human rhabdomyosarcoma cell line, JR-1 and its tumour of origin.

J Clayton, J R Pincott, J A van den Berghe, J T Kemshead.   

Abstract

A new human embryonal rhabdomyosarcoma cell line, designated JR-1, is described that closely resembles the tumour from which it was derived. Comparative studies, by light and electron microscopy reveal morphological features such as myofibre formation, that are concordant with embryonal rhabdomyosarcoma. Immunohistological investigations using a panel of monoclonal antibodies indicate that the cell surface antigen profile of the JR-1 cell line is similar to other embryonal rhabdomyosarcomas. In addition the cell line expresses the cytoplasmic intermediate filament protein desmin, only found in cells of rhabdoid origin. Karyotyping JR-1 shows the cells to contain variable numbers of chromosomes (range 44-100). DNA flow cytometry indicates that cells have an DNA content which is approximately twice normal. The JR-1 cell line has a doubling time of 29 h in culture and, in common with several other human cell lines, produces xenografts in nude mice within 6 weeks of inoculation. With detailed studies on the original tumour and the JR-1 cell line, the latter should prove an excellent model system for investigating the biology of rhabdomyosarcoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3730258      PMCID: PMC2001642          DOI: 10.1038/bjc.1986.155

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Childhood sarcomas and lymphomas. Characterization of new cell lines and search for type-C virus.

Authors:  R M McAllister; W A Nelson-Rees; M Peer; W E Laug; H Isaacs; R V Gilden; R W Rongey; M B Gardner
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

Review 2.  Monoclonal antibodies for analysis of the HLA system.

Authors:  F M Brodsky; P Parham; C J Barnstable; M J Crumpton; W F Bodmer
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Embryonal rhabdomyosarcoma. An ultrastructural study.

Authors:  C Toker
Journal:  Cancer       Date:  1968-06       Impact factor: 6.860

4.  A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.

Authors:  C S Abramson; J H Kersey; T W LeBien
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

5.  Monoclonal antibodies to HLA--DRw determinants.

Authors:  F M Brodsky; P Parham; W F Bodmer
Journal:  Tissue Antigens       Date:  1980-07

6.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

7.  Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain.

Authors:  R H Kennett; F Gilbert
Journal:  Science       Date:  1979-03-16       Impact factor: 47.728

8.  Monoclonal antibody to a plasma membrane antigen of neurons.

Authors:  G S Eisenbarth; F S Walsh; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  Desmin is a specific marker for rhabdomyosarcomas of human and rat origin.

Authors:  M Altmannsberger; K Weber; R Droste; M Osborn
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

10.  P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody.

Authors:  J H Kersey; T W LeBien; C S Abramson; R Newman; R Sutherland; M Greaves
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  11 in total

1.  A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.

Authors:  Katherine K Slemmons; Lisa E S Crose; Stefan Riedel; Manuela Sushnitha; Brian Belyea; Corinne M Linardic
Journal:  Mol Cancer Res       Date:  2017-09-18       Impact factor: 5.852

2.  Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway.

Authors:  Ulrica Tostar; Rune Toftgård; Peter G Zaphiropoulos; Takashi Shimokawa
Journal:  Genes Cancer       Date:  2010-09

3.  In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line.

Authors:  A Ogose; T Motoyama; T Hotta; H Watanabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm.

Authors:  S P Bourne; K Patel; F Walsh; C J Popham; H B Coakham; J T Kemshead
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

5.  Immunohistochemical analysis of neural cell adhesion molecules. Differential expression in small round cell tumors of childhood and adolescence.

Authors:  P Garin-Chesa; E J Fellinger; A G Huvos; H R Beresford; M R Melamed; T J Triche; W J Rettig
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

6.  Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.

Authors:  Alan C Taylor; Katja Schuster; Pamela P McKenzie; Linda C Harris
Journal:  Mol Cancer       Date:  2006-11-02       Impact factor: 27.401

7.  Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Authors:  Ashley R P Hinson; Rosanne Jones; Lisa E S Crose; Brian C Belyea; Frederic G Barr; Corinne M Linardic
Journal:  Front Oncol       Date:  2013-07-17       Impact factor: 6.244

8.  High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line.

Authors:  L R Kelland; L Bingle; S Edwards; G G Steel
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

9.  Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.

Authors:  K Kubo; T Naoe; K R Utsumi; Y Ishiguro; K Ueda; H Shiku; K Yamada
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

10.  Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.

Authors:  K Patel; R J Rossell; L F Pemberton; N K Cheung; F S Walsh; S E Moore; T Sugimoto; J T Kemshead
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.